Cardiac arrest is one of the leading causes of death around the world, killing 7 million to 9 million people a year. With standard care, 1 out of 10 people survive cardiac arrest. Neurescue, founded by Dr. Habib Frost and headquartered in Copenhagen, Denmark, aims to bring that survival rate to 9 out of 10 people with its new device.Currently under U.S. Food and Drug Administration review, the Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies. Standard care in treating cardiac arrest involves chest compressions and defibrillation. This replaces about a third of the blood flow …
Related posts:
There's a controversy over Charlie Munger's design for a big dorm at UCSB
Earnings results so far show companies are effectively navigating supply issues and rising costs
Markets could be challenged in the week ahead as the Fed prepares to reverse easy policy
Where to get the best rates on your emergency savings amid rising inflation
